Raia Drogasil S.A.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Renato Cepollina Raduan
- Full Time Employees
- 73,895
- Sector
- Retail trade
- Industry
- Drugstore chains
- Address
- Av. Corifeu de Azevedo Marques, 3097 Butanta SP Brazil 05339-900
- IPO Date
- Oct 20, 2010
- Website
- rdsaude.com.br
- Similar Companies
- Business
- Raia Drogasil SA (RADL3.SA) operates as Brazil's largest drugstore chain, retailing a broad range of pharmaceutical products, health and beauty items, personal care goods, household essentials, and over-the-counter medications through its Raia and Drogasil banners. The company offers prescription drugs, generic medicines, cosmetics from leading brands, baby products, hygiene supplies, and convenience items such as snacks and beverages; it also provides pharmacy services including vaccinations, blood pressure checks, and medication delivery via its RD app and website. Headquartered in Sao Paulo, Brazil, and founded in 2011 through the merger of Raia SA and Drogasil SA, Raia Drogasil conducts operations exclusively within Brazil, with over 2,800 stores across all regions of the country as of late 2024. In recent developments, the company expanded its store network by opening more than 200 new locations in 2024, strengthening its market leadership in the competitive retail pharmacy sector; it also enhanced its digital ecosystem with upgraded e-commerce capabilities and same-day delivery partnerships in major urban centers. Additionally, Raia Drogasil announced a strategic alliance with select health tech firms in early 2025 to integrate telehealth consultations within its stores, alongside a major funding initiative via a secondary share offering to support accelerated growth amid rising consumer demand for integrated health services. The firm targets middle- and upper-income consumers, families, and chronic disease patients, operating within the retail pharmacy and health & wellness segments without notable subsidiaries or parent entities.
Company News
Village Super Market (NASDAQ:VLGEA) vs. Raia Drogasil (OTCMKTS:RADLY) Head to Head Contrast
Raia Drogasil (OTCMKTS:RADLY) Shares Gap Down – Here’s What Happened
Costco Wholesale (NASDAQ:COST) and Raia Drogasil (OTCMKTS:RADLY) Head-To-Head Contrast
BJ’s Wholesale Club (NYSE:BJ) & Raia Drogasil (OTCMKTS:RADLY) Head to Head Comparison
Head to Head Survey: Ingles Markets (NASDAQ:IMKTA) versus Raia Drogasil (OTCMKTS:RADLY)
Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8%
Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call Transcript
Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Update
Raia Drogasil S.A. (RADLY) Q3 2025 Earnings Call Transcript
Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors
Raia Drogasil: Valuation Burn Now, Healthy Gains Later
What's Hot, What's Not: China Stocks Are Out. Top Picks From 3 Other Countries
3 Stocks to Ride the Latin America Market Boom in 2024
The 3 Best South American Stocks to Buy in 2023